Patritumab deruxtecan, CAS [[2227102-46-5]]

Produktübersicht

• Artikelname: Patritumab deruxtecan, CAS [[2227102-46-5]]
• Artikelnummer: TGM-T77910
• Hersteller Artikelnummer: T77910
• Alternativnummer: TGM-T77910-1MG,TGM-T77910-5MG,TGM-T77910-10MG,TGM-T77910-25MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: MK-1022 , HER3-DXd , HER3DXd , U31287 , U3-1287

Produktbeschreibung

Patritumab deruxtecan (HER3-DXd) is an antibody-drug coupling (ADC) targeting HER3 consisting of a fully humanized anti-HER3 IgG1 monoclonal antibody linked via a cleavable tetrapeptide linker to a topoisomerase I inhibitor payload (an ezetiocan derivative, DXd) for the study of non-small cell lung cancer (NSCLC).

Produkteigenschaften

• Reinheit: 95.00%
• CAS Nummer: [2227102-46-5]
• Target-Kategorie: Antibody-Drug Conjugates (ADCs)